Neoadjuvant endocrine therapy 'a reasonable option' for ER-positive breast cancer

[News]

Endocrine therapy should be reconsidered as a potential option in the neoadjuvant setting for localised oestrogen receptor-positive breast cancer, say the authors of a meta-analysis.

More... (http://www.news-medical.net/news/20160701/Neoadjuvant-endocrine-therapy-a-reasonable-option-for-ER-positive-breast-cancer.aspx)